Merger grants lift Strive, Inc. (ASST) director holdings in Form 4
Rhea-AI Filing Summary
Strive, Inc. director Eric Semler reported large equity awards tied to the closing of the company’s merger with Semler Scientific, Inc. On January 16, 2026, each share of Semler common stock he held was cancelled and converted into the right to receive 21.05 shares of Strive Class A common stock.
As a result, he acquired 13,395,083 shares of Class A common stock directly and 1,637,079 shares indirectly through TCS Capital Advisors, LLC, at a reported price of $0 per share as merger consideration. The filing also shows several fully vested stock options converted into rights to buy Strive Class A shares, including 260,493 options at $1.11, 3,157,500 at $2.80, and additional blocks at exercise prices of $1.72 and $0.85. Indirectly held shares are owned by TCS Capital Advisors, with Semler disclaiming beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 260,493 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 3,157,500 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 1,578,750 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 168,400 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 84,200 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 84,200 | $0.00 | -- |
| Grant/Award | Class A Common Stock | 13,395,083 | $0.00 | -- |
| Grant/Award | Class A Common Stock | 1,637,079 | $0.00 | -- |
Footnotes (1)
- On January 16, 2026, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of September 22, 2025, by and among the Registrant and Semler Scientific, Inc., a Delaware corporation ("Semler," and such merger, the "Merger"), each share of Semler common stock held by the Reporting Person was cancelled and converted into the Reporting Person's right to receive 21.05 shares of Class A Common Stock, par value $0.001 per share, of the Registrant (the "Class A Common Stock"). Represents securities owned directly by TCS Capital Advisors, LLC ("TCS Advisors"). The Reporting Person, by virtue of his position as the managing member of TCS Capital Management, LLC, the investment advisor of TCS Advisors, may be deemed to beneficially own the securities owned directly by TCS Advisors. The Reporting Person expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. On January 16, 2026, in connection with the Merger, each outstanding stock option in respect of the common stock of Semler held by the Reporting Person (each, a "Semler Option") was converted into a right to purchase shares of Class A Common Stock (the "Converted Options") on substantially the same terms and conditions as the Semler Options, except that (i) the number of shares of Semler common stock subject to each such Converted Option equals (x) the number of shares of Semler common stock subject to each such Semler Option, multiplied by (y) 21.05, rounded down to the nearest whole share of Class A Common Stock, (ii) the per share exercise price for each such Converted Option equals (x) the per share exercise price of such Semler Option, divided by (y) 21.05, rounded up to the nearest whole cent and (iii) the Converted Options will be fully vested as of the closing of the Merger. This Converted Option is fully vested and exercisable.
FAQ
What insider activity did Strive, Inc. (ASST) report for Eric Semler?
The Form 4 shows Eric Semler, a director of Strive, Inc., acquiring Class A common stock and stock options on January 16, 2026 in connection with Strive’s merger with Semler Scientific, Inc.
What stock options did Eric Semler hold after the Strive–Semler merger?
The filing lists fully vested stock options to buy Strive Class A shares, including 260,493 options at $1.11, 3,157,500 at $2.80, 1,578,750 at $1.72, and several smaller grants at exercise prices of $2.80, $1.72, and $0.85.
Were the converted stock options from Semler Scientific fully vested?
Yes. The footnotes state that each outstanding Semler option was converted into a Strive Class A option on similar terms and that the Converted Options are fully vested as of the merger closing.